Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis
Metrics: PDF 1941 views | HTML 2204 views | ?
Jie Jiang1, Guojun Geng1, Xiuyi Yu1, Hongming Liu1, Jing Gao1, Hanxiang An2, Chengfu Cai1, Ning Li1, Dongyan Shen3, Xiaoqiang Wu3, Lisheng Zheng4, Yanjun Mi1,2, Shuyu Yang5
1Department of Thoracic Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, People’s Republic of China
2Department of Medical Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, People’s Republic of China
3Biobank, The First Affiliated Hospital of Xiamen University, Xiamen, People’s Republic of China
4Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, People’s Republic of China
5Xiamen Diabetes Institution, The First Affiliated Hospital of Xiamen University, Xiamen, People’s Republic of China
Shuyu Yang, email: [email protected]
Yanjun Mi, email: [email protected]
Keywords: dihydroartemisinin, non-small-cell lung cancer, Warburg effect, metastasis, NF-κB
Received: April 06, 2016 Accepted: November 02, 2016 Published: November 24, 2016
Non-small-cell lung cancer (NSCLC) is an aggressive malignancy and long-term survival remains unsatisfactory for patients with metastatic and recurrent disease. Repurposing the anti-malarial drug dihydroartemisinin (DHA) has been proved to possess potent antitumor effect on various cancers. However, the effects of DHA in preventing the invasion of NSCLC cells have not been studied. In the present study, we determined the inhibitory effects of DHA on invasion and migration and the possible mechanisms involved using A549 and H1975 cells. DHA inhibited in vitro migration and invasion of NSCLC cells even in low concentration with little cytotoxicity. Additionally, low concentration DHA also inhibited Warburg effect in NSCLC cells. Mechanically, DHA negatively regulates NF-κB signaling to inhibit the GLUT1 translocation. Blocking the NF-κB signaling largely abolishes the inhibitory effects of DHA on the translocation of GLUT1 to the plasma membrane and the Warburg effect. Furthermore, GLUT1 knockdown significantly decreased the inhibition of invasion, and migration by DHA. Our results suggested that DHA can inhibit metastasis of NSCLC by targeting glucose metabolism via inhibiting NF-κB signaling pathway and DHA may deserve further investigation in NSCLC treatment.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.